Chelation Therapy

Podcast
hoffmanpodcastlogo

Intelligent Medicine Radio Show for April 1, Part 2
April 3, 2017
How high doses of vitamin C curtail cold symptoms; Pricey new cholesterol drugs have only moderate effects on heart risks; How effective are knee injections for osteoarthritis? Is the "NJ Diet" program any good? Are statins worthwhile for heart patients over 80? Is vitamin K compatible with blood-thinning meds? Rating "oral chelation" products; CoQ10 vs. metabolic syndrome. Click HERE for part 1. Click HERE for articles and resources relating to this podcast episode.



Share:



hoffmanpodcastlogo

Chelation, A Potentially Lifesaving Therapy, Part 1
February 21, 2017
If you or a loved one is a diabetic over 50 who has suffered a heart attack, there's an opportunity to obtain a potentially lifesaving therapy AT NO CHARGE. Dr. Dana Cohen describes the TACT2 trial, a multi-million dollar government-sponsored study to evaluate the effectiveness of chelation therapy. What is chelation? What is its history? How did the first TACT study demonstrate its effectiveness? Why was it greeted with skepticism by the medical establishment? Why have only integrative doctors been eager to embrace chelation? Click HERE for part 2.



Share:



hoffmanpodcastlogo

Chelation, A Potentially Lifesaving Therapy, Part 2

Dr. Hoffman continues his conversation with Dr. Dana Cohen about the TACT2 trial to evaluate the effectiveness of chelation therapy. Click HERE for part 1.



Share:



hoffmanpodcastlogo

Chelation Therapy’s Dramatic Effects, Part 1
January 21, 2016
Remember the big story about 2014’s TACT Study (the Trial to Assess Chelation Therapy)? Well, in light of its success, now there’s going to be a followup study, TACT 2. Dr. Tony Lamas, the TACT Director, joins us to discuss the implications of the original TACT Study, and what we can expect from TACT 2. The results of TACT were a surprise to the medical community—they strongly suggest that intravenous chelation with EDTA can reduce the risk of subsequent cardiac events in heart attack sufferers. The protective effect was particularly dramatic in diabetic patients. Why were the results greeted with such skepticism? Why isn’t chelation now being embraced by the medical community? Now that we know chelation works, do we know how? What additional information is being sought in TACT 2? What insights does TACT bring us for our understanding of how environmental heavy metals like lead and cadmium promote disease? Were the vitamins that patients took in the TACT Study beneficial? Click HERE for part 2.



Share:



hoffmanpodcastlogo

Chelation Therapy’s Dramatic Effects, Part 2

Dr. Hoffman continues his conversation with Dr. Tony Lamas, Director of TACT (the Trial to Assess Chelation Therapy). Click HERE for part 1.



Share:



Dr. Hoffman's Supplement Store
Facebook Twitter RSS Stitcher iTunes

TWITTER